demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
infections other than COVID-19
vaccines
ebola vaccine EBOVAC2 Ishola ...
Non replicating viral vector
Ad26.RSV.preF (respiratory syncytial virus) Sadoff
Ad26.ZEBOV () Afolabi
Ad26.ZIKV.001 (Ad26-Vectored Anti-Zika Virus Vaccine) Salisch

20 studies excluded by filtering options 2

4830 NCT04276896, 0 2300excludednot a RCTrisk of bias not avaialble
6966 Ou, 2021 2320excludednot a RCTrisk of bias not avaialble
7070 PHE variants (Technical briefing 12 22 may 2021), 2021 2202excludednot a RCT
7420 PHE (Stowe), 2021 2133excludednot a RCThigh risk of bias
8149 PHE Technical briefing 16 (11/18 June 2021), 2021 2133excludednot a RCThigh risk of bias
8248 Montgomery, 2021 2130excludednot a RCTrisk of bias not avaialble
8275 Musser, 2021 2130excludednot a RCTrisk of bias not avaialble
8350 Rosenberg, 2021 2130excludednot a RCTrisk of bias not avaialble
8515 Scobie, 2021 2200excludednot a RCTrisk of bias not avaialble
9065 Ruddy, 2021 2320excludednot a RCTrisk of bias not avaialble
9129 COV-BOOST, 2021 210excludedrisk of bias not avaialble
9130 Gilboa, 2021 200excludedrisk of bias not avaialble
9170 UKHSA report 33 (23 december 2021), 2021 2200excludednot a RCTrisk of bias not avaialble
9176 UKHSA 31 december 2021, 2021 2200excludednot a RCTrisk of bias not avaialble
9178 Liu, 2021 210excludedrisk of bias not avaialble
9214 Southern California (Lewnard), 2022 2130excludednot a RCTrisk of bias not avaialble
9240 Chen, 2021 210excludedrisk of bias not avaialble
9275 Mattiuzzi, 2022 200excludedrisk of bias not avaialble
9290 Danza, 2022 2320excludednot a RCTrisk of bias not avaialble
9294 UKHSA (report W4- 27 January), 2022 2120excludednot a RCTrisk of bias not avaialble